Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics - 31 Year Stock Price History | NKTR

Historical daily share price chart and data for Nektar Therapeutics since 1994 adjusted for splits and dividends. The latest closing stock price for Nektar Therapeutics as of May 05, 2025 is 0.69.
  • The all-time high Nektar Therapeutics stock closing price was 108.44 on March 08, 2018.
  • The Nektar Therapeutics 52-week high stock price is 1.93, which is 179.7% above the current share price.
  • The Nektar Therapeutics 52-week low stock price is 0.43, which is 37.7% below the current share price.
  • The average Nektar Therapeutics stock price for the last 52 weeks is 1.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Nektar Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.8072 0.9610 1.1900 0.4904 0.6872 -26.11%
2024 1.1414 0.5948 1.8300 0.4936 0.9300 64.60%
2023 0.9654 2.1900 3.1500 0.4227 0.5650 -75.00%
2022 5.2973 13.6600 13.7200 2.0300 2.2600 -83.27%
2021 17.3794 17.6600 25.4600 10.8300 13.5100 -20.53%
2020 19.8952 20.9600 27.9600 14.4700 17.0000 -21.24%
2019 29.0393 34.2200 46.3500 15.8700 21.5850 -34.33%
2018 64.8573 57.6500 108.4400 30.4300 32.8700 -44.96%
2017 23.6689 12.6900 60.5000 11.7500 59.7200 386.72%
2016 14.6323 16.2000 19.6800 11.0000 12.2700 -27.18%
2015 12.6614 15.1650 17.4100 9.5000 16.8500 8.71%
2014 13.0098 11.8700 17.0500 10.5300 15.5000 36.56%
2013 10.6668 7.5400 13.9600 7.5400 11.3500 53.17%
2012 7.8108 5.7600 10.8300 5.6800 7.4100 32.44%
2011 7.5754 12.5300 12.5300 4.2200 5.5950 -56.46%
2010 13.4286 9.6800 15.8800 9.3900 12.8500 37.88%
2009 6.9009 5.7900 10.4700 4.0300 9.3200 67.63%
2008 5.0190 6.6000 7.5000 2.8300 5.5600 -17.14%
2007 9.9415 15.2400 15.2400 5.2200 6.7100 -55.88%
2006 17.8384 16.4400 22.7500 13.1000 15.2100 -7.59%
2005 16.7194 19.7600 19.8000 13.4100 16.4600 -18.68%
2004 17.5096 14.3000 23.2400 9.6900 20.2400 48.71%
2003 9.7929 8.5600 14.9410 4.4600 13.6100 68.44%
2002 8.7522 18.2200 18.2200 4.1300 8.0800 -56.44%
2001 22.9463 44.5000 48.2500 11.0100 18.5500 -63.27%
2000 43.1315 20.8438 63.3125 20.8438 50.5000 137.30%
1999 14.5146 17.0000 21.8438 11.5000 21.2813 28.98%
1998 14.1300 12.8438 17.1250 10.7500 16.5000 26.92%
1997 11.8157 7.6250 18.2500 7.6250 13.0000 71.90%
1996 7.5806 5.1250 10.3125 5.0000 7.5625 55.13%
1995 4.8710 4.5000 7.1875 3.5000 4.8750 5.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.140B $0.098B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $98.106B 36.80
Zoetis (ZTS) United States $70.247B 26.59
Daiichi Sankyo, - (DSNKY) Japan $49.445B 25.16
Takeda Pharmaceutical (TAK) Japan $48.747B 10.79
Summit Therapeutics (SMMT) United States $20.720B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.545B 0.00
Merck (MKKGY) Germany $18.346B 15.18
Shionogi (SGIOY) Japan $14.436B 0.00
United Therapeutics (UTHR) United States $13.288B 11.76
Neurocrine Biosciences (NBIX) United States $10.852B 33.34
IPSEN (IPSEY) France $9.920B 0.00
Orion OYJ (ORINY) Finland $8.948B 24.20
Corcept Therapeutics (CORT) United States $7.717B 58.69
Madrigal Pharmaceuticals (MDGL) United States $7.005B 0.00
Stevanato Group S.p.A (STVN) Italy $6.475B 41.12
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.217B 0.00
Grifols, S.A (GRFS) Spain $5.054B 0.00
Soleno Therapeutics (SLNO) United States $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.470B 13.51
Hypermarcas (HYPMY) Brazil $2.350B 15.46
Recursion Pharmaceuticals (RXRX) United States $2.291B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.868B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Indivior (INDV) United States $1.652B 7.01
Guardian Pharmacy Services (GRDN) United States $1.632B 0.00
Evotec AG (EVO) Germany $1.523B 0.00
ARS Pharmaceuticals (SPRY) United States $1.420B 180.75
Ocular Therapeutix (OCUL) United States $1.402B 0.00
Dyne Therapeutics (DYN) United States $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.122B 45.61
Enliven Therapeutics (ELVN) United States $1.006B 0.00
Ardelyx (ARDX) United States $0.988B 0.00
Harrow (HROW) United States $0.948B 0.00
Collegium Pharmaceutical (COLL) United States $0.888B 4.72
Avadel Pharmaceuticals (AVDL) Ireland $0.840B 0.00
Xencor (XNCR) United States $0.801B 0.00
AleAnna (ANNA) United States $0.758B 0.00
Xeris Biopharma Holdings (XERS) United States $0.737B 0.00
Cronos Group (CRON) Canada $0.709B 0.00
KalVista Pharmaceuticals (KALV) United States $0.674B 0.00
Organogenesis (ORGO) United States $0.670B 0.00
Akebia Therapeutics (AKBA) United States $0.641B 0.00
Bioventus (BVS) United States $0.601B 15.62
Savara (SVRA) United States $0.587B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.92
Relay Therapeutics (RLAY) United States $0.554B 0.00
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.519B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.474B 0.00
Verve Therapeutics (VERV) United States $0.463B 0.00
Elite Pharmaceuticals (ELTP) United States $0.453B 0.00
Altimmune (ALT) United States $0.444B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
CytoDyn (CYDY) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 6.87
Oruka Therapeutics (ORKA) United States $0.401B 0.00
Heron Therapeutics (HRTX) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 20.60
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Avita Medical (RCEL) United States $0.244B 0.00
Wellgistics Health (WGRX) United States $0.232B 0.00
ProKidney (PROK) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.15
Esperion Therapeutics (ESPR) United States $0.216B 27.25
OmniAb (OABI) United States $0.214B 0.00
Korro Bio (KRRO) United States $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.190B 0.00
MediWound (MDWD) Israel $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.174B 0.00
Aldeyra Therapeutics (ALDX) United States $0.168B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.151B 46.62
Procaps Group, S.A (PROCF) Luxembourg $0.141B 0.00
Protara Therapeutics (TARA) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.089B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.080B 13.11
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.078B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Karyopharm Therapeutics (KPTI) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Avalo Therapeutics (AVTX) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 7.75
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.95
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.19
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00